SCHEMBL798942

SCHEMBL798942

CCOC(=O)N(CC)c1cn(CC)c2ccccc12

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 1/20 0.49
MAPT P10636 4/20 0.44
ALDH1A1 P00352 4/20 0.44
LMNA P02545 2/20 0.43
CREBBP Q92793 1/20 0.43
BRCA1 P38398 1/20 0.43
POLB P06746 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
USP2 O75604 1/20 0.42
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
F2RL3 Q96RI0 1/20 0.40
TSPO P30536 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28805707 0.83 CHRM1 (0.54) ALDH1A1LMNAPOLBSMN1; SMN2F2RL3
SCHEMBL997654 0.75 SIGMAR1 (0.43) ALDH1A1LMNACYP1A2CYP3A4NPSR1
SCHEMBL8966581 0.73 SIGMAR1 (0.56) MAPTALDH1A1LMNAL3MBTL1NPSR1
SCHEMBL2090257 0.73 NR4A2 (0.76) NR4A2ALDH1A1LMNACREBBPPOLB
SCHEMBL7056985 0.70 LMNA (0.69) NR4A2MAPTALDH1A1LMNACREBBP
SCHEMBL28026387 0.69 NR4A2 (0.60) NR4A2MAPTALDH1A1LMNACREBBP
SCHEMBL28812330 0.69 ALDH1A1 (0.57) MAPTALDH1A1LMNACREBBPPOLB
SCHEMBL1400828 0.69 ALDH1A1 (0.63) MAPTALDH1A1LMNAPOLBL3MBTL1
SCHEMBL11768823 0.68 ALDH1A1 (0.42) MAPTALDH1A1LMNAL3MBTL1SMN1; SMN2
SCHEMBL798421 0.68 NR4A2 (0.48) NR4A2MAPTALDH1A1LMNACREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2627648-A1 17aHYDROXYLASE/C17,20-LYASE INHIBITORS Novartis AG (CH) 2013-08-21 EP disclosed
WO-2012035078-A1 17α-HYDROXYLASE/C17,20-LYASE INHIBITORS NOVARTIS AG (CH) 2012-03-22 WO disclosed